Enoblituzumab Uses, Dosage, Side Effects and more

Enoblituzumab is under investigation in clinical trial NCT02982941 (Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors).

Trade Name Enoblituzumab
Generic Enoblituzumab
Enoblituzumab Other Names Enoblituzumab
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share